mywealthgrid
Overview
Dashboard
My workspace
My PortfolioWatchlistsFollowingScreenersAlertsResearch
Discover
CompaniesSectorsIndicesMutual fundsInstitutional investorsCompareTrade trends
Market updates
ResultsAnnouncementsSearch filingsCalendarUpcoming listings
Sign in to save your work
Sign inSign up
Loading page…
QB

Q-Line Biotech Limited

NSE:QLINESME
UnclassifiedUnclassified
₹661.1
-2.92%1 Oct close
Mkt cap
—
Watch Alert Compare
OverviewChartPeersProfit & lossBalance sheetCash flowRatiosShareholdingF&OFund holdersDocumentsEventsAnnouncementsNotes
ConsolidatedStandalone

Consolidated figures

RatioMar 2026
Margins
Gross margin %60.8%
EBITDA margin %28.7%
EBIT margin %25.5%
PAT margin %16.3%
Working capital
Receivable days—
Inventory days258
Payable days—
NWC days—
Leverage
Current ratio1.64
Debt to EBITDA—
Debt to equity—
Interest coverage4.8
Asset turnover0.61
Return ratios
Return on assets %10%
Return on capital employed %26.7%
Return on equity %—

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.